Autor: |
Gram, J, Hansen, TB, Jensen, PB, Christensen, JH, Ladefoged, S, Pedersen, FB |
Zdroj: |
Nephrology Dialysis Transplantation; Jun1998, Vol. 13 Issue 6, p1529-1534, 6p |
Abstrakt: |
Background: Uraemia and chronical haemodialysis are associated with an abnormal growth hormone (GH)-insulin-like growth factor (IGF) axis which may contribute to malnutrition and renal bone disease. Short-term studies have shown a beneficial effect of treatment with recombinant human growth hormone (rhGH) on nutritional status in patients on haemodialysis. In the present study, we evaluated the effect of rhGH on bone and mineral metabolism. [ABSTRACT FROM PUBLISHER] |
Databáze: |
Complementary Index |
Externí odkaz: |
|